89bio Inc (ETNB)
8.98
+0.01
(+0.11%)
USD |
NASDAQ |
May 20, 16:00
9.13
+0.15
(+1.67%)
After-Hours: 17:27
89bio Cash and Short Term Investments (Quarterly): 562.29M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 562.29M |
| December 31, 2023 | 578.87M |
| September 30, 2023 | 448.30M |
| June 30, 2023 | 478.00M |
| March 31, 2023 | 480.88M |
| December 31, 2022 | 188.16M |
| September 30, 2022 | 193.34M |
| June 30, 2022 | 139.32M |
| March 31, 2022 | 126.09M |
| December 31, 2021 | 150.72M |
| September 30, 2021 | 157.33M |
| Date | Value |
|---|---|
| June 30, 2021 | 170.96M |
| March 31, 2021 | 189.62M |
| December 31, 2020 | 204.63M |
| September 30, 2020 | 219.15M |
| June 30, 2020 | 73.90M |
| March 31, 2020 | 85.53M |
| December 31, 2019 | 93.34M |
| September 30, 2019 | 16.19M |
| June 30, 2019 | 21.92M |
| December 31, 2018 | 11.23M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
16.19M
Minimum
Sep 2019
578.87M
Maximum
Dec 2023
228.93M
Average
179.56M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Akero Therapeutics Inc | 903.66M |
| Madrigal Pharmaceuticals Inc | 1.059B |
| Viking Therapeutics Inc | 962.98M |
| Galectin Therapeutics Inc | 23.56M |
| Terns Pharmaceuticals Inc | 240.65M |